Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001367644-22-000107
Filing Date
2022-07-22
Accepted
2022-07-22 16:09:12
Documents
3
Period of Report
2022-07-15

Document Format Files

Seq Description Document Type Size
1 FORM 3 wf-form3_165852053481101.html 3  
1 FORM 3 wf-form3_165852053481101.xml 3 2277
2 DAYAL POA a2022.htm EX-24 572
3 DAYAL POA a2022001.jpg GRAPHIC 284563
  Complete submission text file 0001367644-22-000107.txt   396243
Mailing Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879
Business Address 400 PROFESSIONAL DR, SUITE 400 GAITHERSBURG MD 20879 240-631-3200
Emergent BioSolutions Inc. (Issuer) CIK: 0001367644 (see all company filings)

EIN.: 141902018 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BIOMET, INC. P.O. BOX 587 WARSAW IN 46581-0587
Business Address
Dayal Sujata Tyagi (Reporting) CIK: 0001536908 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-33137 | Film No.: 221100060